Perinatal HIV Transmission Prevention Strategies in 2020

Perinatal HIV transmission can occur during pregnancy, labor, delivery, or breastfeeding, yet timely clinical care can reduce the risk to very low levels. In 2020, prevention depended on a coordinated pathway: early diagnosis, effective antiretroviral therapy, viral-load monitoring, safe obstetric management, newborn prophylaxis, and follow-up testing.

The subject was especially relevant to the international perinatal and neonatal medicine community gathered around the planned FAOPS and PREBIC AA meetings in Tokyo. The FAOPS 2020 congress site preserved information about the scientific program, speakers, abstracts, and clinical research discussions, although the congress was canceled in April 2020 because the COVID-19 pandemic disrupted travel and international meetings.

A prevention strategy must also account for real-life conditions. A pregnant person may enter care late, face stigma, lack stable housing, or have difficulty obtaining medicines. The strongest programs therefore combine biomedical treatment with confidential counseling, mental health support, family services, and practical help with appointments and medication access.

How Transmission Occurs

HIV may cross the placenta, although transmission during pregnancy is less common than exposure during labor, delivery, or breastfeeding. The amount of virus in the mother’s blood, especially near birth, is one of the clearest predictors of transmission risk. A high or unknown viral load requires rapid clinical assessment and a carefully coordinated delivery plan.

Antiretroviral therapy suppresses HIV replication and reduces the amount of virus circulating in the body. When treatment is started early and taken consistently, viral suppression can be achieved before delivery. However, a diagnosis late in pregnancy still offers an opportunity to prevent infection. Immediate linkage to an HIV specialist, baseline laboratory testing, and prompt treatment can make a meaningful difference.

The infant’s exposure does not end at birth in settings where breastfeeding is recommended. HIV can be transmitted through breast milk, so infant-feeding counseling must reflect national guidance, the safety of replacement feeding, access to clean water, cultural circumstances, and the parent’s informed preferences. Advice should be consistent, respectful, and free from blame.

Maternal Diagnosis And Antiretroviral Treatment

Routine HIV testing during antenatal care was a central prevention measure in 2020. Opt-out testing helped make screening part of standard pregnancy services, while repeat testing later in pregnancy was appropriate for people with ongoing exposure risk or who lived in areas with substantial HIV incidence. Testing the partner and offering prevention services could also reduce the risk of new infection during pregnancy.

A positive result should lead to same-day or rapid referral rather than a long administrative delay. Treatment guidelines in 2020 generally favored potent combination antiretroviral therapy for pregnant people, with regimens selected according to resistance patterns, drug interactions, prior treatment, safety data, and local availability. Dolutegravir-based therapy was increasingly important because of its strong viral suppression and good tolerability, while clinicians continued to consider pregnancy-specific evidence and individual circumstances.

Viral-load testing is essential because it turns treatment into a measurable prevention tool. A result late in pregnancy helps determine the delivery approach and the intensity of newborn prophylaxis. If viral load remains detectable, clinicians should explore adherence barriers, drug resistance, malabsorption, interruptions in supply, and the possibility of a recent infection.

Counseling should explain that treatment protects health and reduces the chance of passing HIV to the infant, but it must not become a source of coercion. Clear instructions, simplified dosing, transportation support, and nonjudgmental follow-up often matter as much as the prescription itself.

Care During Labor And Delivery

When viral load is suppressed near delivery, vaginal birth is generally appropriate unless another obstetric indication points to cesarean birth. If the viral load is above the local threshold, often 1,000 copies/mL, or is unknown close to labor, a planned cesarean may be considered to reduce exposure during delivery. National protocols varied, so decisions needed to be made with an obstetric and HIV care team.

Intrapartum management aimed to limit contact between the infant and infected blood or genital secretions. Unnecessary invasive procedures, such as fetal scalp electrodes and fetal scalp sampling, were usually avoided. Artificial rupture of membranes and prolonged rupture were assessed carefully, while routine obstetric safety remained the priority. HIV status should never justify unsafe care or stigmatizing treatment.

Intravenous zidovudine during labor was used selectively in some 2020 protocols, particularly when viral load was high or unknown, rather than automatically for every patient. The decision depended on current viral-load results, treatment history, adherence, and national recommendations. Good documentation and communication between antenatal, obstetric, anesthesia, and neonatal teams reduced avoidable gaps.

The newborn should receive antiretroviral prophylaxis as soon as possible after birth, ideally within hours. The regimen and duration depended on the estimated transmission risk. Infants at higher risk might receive a combination regimen, while those at lower risk could receive a shorter or simpler course under local guidance.

Newborn Testing And Infant Follow-Up

Maternal HIV antibodies can cross the placenta, meaning an antibody test alone cannot diagnose HIV infection in a young infant. Virologic testing, usually using HIV nucleic acid testing, was therefore required for exposed infants. Early infant diagnosis could identify infection within the first weeks of life and enable treatment before symptoms developed.

Testing schedules varied by national program and feeding practice, but commonly included a test around four to six weeks and additional tests after exposure ended. A positive result needed urgent confirmation and referral for pediatric HIV treatment. A negative early test did not always end follow-up, particularly when breastfeeding continued or when the infant had received intensive prophylaxis.

Newborn care also included cotrimoxazole prophylaxis at the recommended age, immunizations, growth monitoring, and assessment for feeding difficulties. Families needed a written plan explaining medication doses, test dates, warning signs, and where to obtain help. Missed appointments were best addressed through outreach rather than punishment.

The transition from maternity care to primary pediatric and HIV services was a vulnerable point. Assigning responsibility to a named clinician or care team could prevent test results from being lost. Confidential records were particularly important in communities where HIV-related stigma might expose the parent or child to discrimination.

Mental Health, Stigma, And COVID-19 Disruption

An HIV diagnosis during pregnancy can trigger fear about health, relationships, parenting, and disclosure. Depression, anxiety, intimate-partner violence, and social isolation may interfere with adherence and follow-up. Perinatal services should screen for emotional distress and safety concerns while offering counseling, peer support, and referral to specialized mental health care.

The discussion of maternal mental health during the COVID-19 pandemic is relevant to HIV prevention because emotional well-being affects engagement with antenatal and neonatal services. Support should be confidential and culturally appropriate, with interpreters and community health workers included when helpful.

The pandemic introduced additional barriers in 2020. Lockdowns, overwhelmed hospitals, transport restrictions, medicine shortages, and fear of infection could interrupt HIV treatment. Services responded in different ways, including multi-month dispensing, telephone consultations, community medicine delivery, flexible appointment scheduling, and separation of antenatal care from infectious-disease triage where possible.

Continuity planning needed to include the infant. Parents should leave the maternity unit with enough medication, clear instructions, and a documented testing schedule. Remote care could support adherence, but it could not replace laboratory monitoring, clinical examination, or urgent evaluation when complications arose.

Practical Priorities For Health Services

Effective programs integrated HIV prevention into ordinary maternal and newborn care rather than treating it as a separate pathway. Midwives, obstetricians, pediatricians, pharmacists, laboratory staff, social workers, and community organizations each had a role. Shared protocols helped ensure that a positive antenatal test led smoothly to treatment, delivery planning, neonatal prophylaxis, and testing.

Quality improvement also required attention to equity. Adolescents, migrants, people who inject drugs, individuals in rural areas, and those with limited legal or financial security could face additional obstacles. Services that protected confidentiality, reduced clinic visits, offered translation, and avoided judgment were more likely to retain families through the full prevention cascade.

Health professionals could prioritize the following actions:

• Offer HIV testing early in pregnancy and repeat it when exposure risk or local guidance warrants.
• Start effective antiretroviral therapy promptly and monitor viral load before delivery.
• Create a documented birth and newborn prophylaxis plan before labor begins.
• Arrange virologic infant testing, medication supplies, feeding counseling, and follow-up before discharge.
• Protect mental health, confidentiality, and continuity of care during public health emergencies.

Turning Prevention Into Continuity Of Care

Perinatal HIV prevention in 2020 was a series of linked decisions rather than a single intervention. The outcome depended on whether testing led to treatment, treatment led to viral suppression, viral-load information reached the delivery team, and newborn care continued after discharge. Each handoff represented an opportunity to prevent transmission or a risk of losing contact.

The same framework remains useful for evaluating maternal and neonatal services today: diagnose early, treat effectively, measure viral suppression, plan delivery, protect the newborn, and support the family. Clinical protocols should be adapted to current evidence and national policy, while the underlying principle remains constant—every pregnant person deserves respectful, timely, coordinated care.

Health professionals, researchers, and service planners can use the FAOPS 2020 clinical context as a reminder to strengthen collaboration across perinatal HIV programs. Apply these prevention principles in practice, share reliable guidance with care teams, and help ensure that every exposed infant receives prompt prophylaxis, testing, and follow-up.